Phycocyanobilin Attenuates Oligomerized Amyloid Β-Induced Neuronal Senescence Through Sirt1-Associated Mechanisms

Aging Pathway
Therapeutic
Phycocyanobilin, a compound derived from algae, was found to reduce the aging-like changes in brain cells induced by amyloid-beta, a protein associated with Alzheimer’s disease, by influencing a protein called SIRT1.
Author

Gemini

Published

August 17, 2026

Our brain cells can undergo a process called “senescence,” where they essentially get old and stop functioning properly, contributing to diseases like Alzheimer’s. This cellular aging is often triggered by harmful proteins, such as amyloid-beta, which accumulate in the brain. Researchers have been exploring natural compounds that might protect our brain cells from this detrimental process.

A recent study investigated a promising compound called phycocyanobilin (PCB), which is found in certain types of algae. The findings suggest that PCB can significantly counteract the aging-like effects that amyloid-beta has on brain cells.

How does it work? The research indicates that PCB exerts its protective effects, at least in part, by interacting with a key protein known as sirtuin 1 (SIRT1). SIRT1 is often referred to as a “longevity protein” because it plays a crucial role in maintaining cell health and function, and its activity tends to decline with age and in diseases like Alzheimer’s.

By restoring the levels and activity of SIRT1, PCB helps to reduce cell damage, lower inflammation, and decrease other markers associated with cellular senescence in brain cells exposed to amyloid-beta. This suggests that this natural compound could offer a novel approach to protecting our brains from the aging processes linked to Alzheimer’s disease.


Source: link to paper